PetMed Express names Sandra Campos CEO; Hulett resigns with severance

PETMED EXPRESS INC

Matt Hulett resigned as CEO, President, and director on April 29; will remain as advisor through Aug 30.
Sandra Campos, previously a board member, appointed CEO and President effective immediately; remains on board.
Campos receives $550K base salary, $120K signing bonus, target bonus 100% of base, and $2M initial RSU grant.
Hulett receives severance through Aug 30: base salary continuation, COBRA reimbursement, and accelerated vesting of 30,000 restricted shares.

item 5.02 item 7.01 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Sandra Campos

Chief Executive Officer and President

PETS · PETMED EXPRESS INC

Effective: 2024-04-29
Filed: April 29, 2024, 7:59 PM ET

the Company appointed Sandra Campos, an existing director of the Company, as the Company’s new Chief Executive Officer and President.

Departed

Mathew Hulett

President and Chief Executive Officer

PETS · PETMED EXPRESS INC

Effective: 2024-04-29
Successor: Sandra Campos
Filed: April 29, 2024, 7:59 PM ET

Mr. Hulett resigned as President and Chief Executive Officer, and also as a director, of the Company effective April 29, 2024

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Sandra Campos was appointed as Chief Executive Officer and President at PETMED EXPRESS INC.

Action: appointed
Role: Chief Executive Officer and President

Exact text from the filing

the Company appointed Sandra Campos, an existing director of the Company, as the Company’s new Chief Executive Officer and President.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Mathew Hulett resigned as President and Chief Executive Officer at PETMED EXPRESS INC.

Action: resigned
Role: President and Chief Executive Officer

Exact text from the filing

Mr. Hulett resigned as President and Chief Executive Officer, and also as a director, of the Company effective April 29, 2024

View on SEC.gov

PETMED EXPRESS INC filing history →

Source: SEC EDGAR

accession 0001040130-24-000022

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.